Global Decentralized Clinical Trials (DCTs) Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 265389
  • calendar_today Published On: Jan, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Decentralized Clinical Trials (DCTs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Decentralized Clinical Trials (DCTs) market size is estimated to be worth US$ 7341.6 million in 2021 and is forecast to a readjusted size of USD 18560 million by 2028 with a CAGR of 14.2% during review period. Oncology accounting for % of the Decentralized Clinical Trials (DCTs) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Interventional segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Decentralized Clinical Trials (DCTs) include Medidata, IQVIA, Labcorp, PRA Health Sciences, and Parexel, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Decentralized Clinical Trials (DCTs) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Interventional

Observational

Expanded Access

Market segment by Application, can be divided into

Oncology

Cardiovascular

Others

Market segment by players, this report covers

Medidata

IQVIA

Labcorp

PRA Health Sciences

Parexel

ICON

Oracle

CRF Health

Clinical Ink

Medable

Science 37

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Decentralized Clinical Trials (DCTs) product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Decentralized Clinical Trials (DCTs), with revenue, gross margin and global market share of Decentralized Clinical Trials (DCTs) from 2019 to 2022.

Chapter 3, the Decentralized Clinical Trials (DCTs) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Decentralized Clinical Trials (DCTs) market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Decentralized Clinical Trials (DCTs) research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Decentralized Clinical Trials (DCTs)

1.2 Classification of Decentralized Clinical Trials (DCTs) by Type

1.2.1 Overview: Global Decentralized Clinical Trials (DCTs) Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Type in 2021

1.2.3 Interventional

1.2.4 Observational

1.2.5 Expanded Access

1.3 Global Decentralized Clinical Trials (DCTs) Market by Application

1.3.1 Overview: Global Decentralized Clinical Trials (DCTs) Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Oncology

1.3.3 Cardiovascular

1.3.4 Others

1.4 Global Decentralized Clinical Trials (DCTs) Market Size & Forecast

1.5 Global Decentralized Clinical Trials (DCTs) Market Size and Forecast by Region

1.5.1 Global Decentralized Clinical Trials (DCTs) Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Decentralized Clinical Trials (DCTs) Market Size by Region, (2017-2022)

1.5.3 North America Decentralized Clinical Trials (DCTs) Market Size and Prospect (2017-2028)

1.5.4 Europe Decentralized Clinical Trials (DCTs) Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size and Prospect (2017-2028)

1.5.6 South America Decentralized Clinical Trials (DCTs) Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Decentralized Clinical Trials (DCTs) Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Decentralized Clinical Trials (DCTs) Market Drivers

1.6.2 Decentralized Clinical Trials (DCTs) Market Restraints

1.6.3 Decentralized Clinical Trials (DCTs) Trends Analysis

2 Company Profiles

2.1 Medidata

2.1.1 Medidata Details

2.1.2 Medidata Major Business

2.1.3 Medidata Decentralized Clinical Trials (DCTs) Product and Solutions

2.1.4 Medidata Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Medidata Recent Developments and Future Plans

2.2 IQVIA

2.2.1 IQVIA Details

2.2.2 IQVIA Major Business

2.2.3 IQVIA Decentralized Clinical Trials (DCTs) Product and Solutions

2.2.4 IQVIA Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 IQVIA Recent Developments and Future Plans

2.3 Labcorp

2.3.1 Labcorp Details

2.3.2 Labcorp Major Business

2.3.3 Labcorp Decentralized Clinical Trials (DCTs) Product and Solutions

2.3.4 Labcorp Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Labcorp Recent Developments and Future Plans

2.4 PRA Health Sciences

2.4.1 PRA Health Sciences Details

2.4.2 PRA Health Sciences Major Business

2.4.3 PRA Health Sciences Decentralized Clinical Trials (DCTs) Product and Solutions

2.4.4 PRA Health Sciences Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 PRA Health Sciences Recent Developments and Future Plans

2.5 Parexel

2.5.1 Parexel Details

2.5.2 Parexel Major Business

2.5.3 Parexel Decentralized Clinical Trials (DCTs) Product and Solutions

2.5.4 Parexel Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Parexel Recent Developments and Future Plans

2.6 ICON

2.6.1 ICON Details

2.6.2 ICON Major Business

2.6.3 ICON Decentralized Clinical Trials (DCTs) Product and Solutions

2.6.4 ICON Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 ICON Recent Developments and Future Plans

2.7 Oracle

2.7.1 Oracle Details

2.7.2 Oracle Major Business

2.7.3 Oracle Decentralized Clinical Trials (DCTs) Product and Solutions

2.7.4 Oracle Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Oracle Recent Developments and Future Plans

2.8 CRF Health

2.8.1 CRF Health Details

2.8.2 CRF Health Major Business

2.8.3 CRF Health Decentralized Clinical Trials (DCTs) Product and Solutions

2.8.4 CRF Health Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 CRF Health Recent Developments and Future Plans

2.9 Clinical Ink

2.9.1 Clinical Ink Details

2.9.2 Clinical Ink Major Business

2.9.3 Clinical Ink Decentralized Clinical Trials (DCTs) Product and Solutions

2.9.4 Clinical Ink Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Clinical Ink Recent Developments and Future Plans

2.10 Medable

2.10.1 Medable Details

2.10.2 Medable Major Business

2.10.3 Medable Decentralized Clinical Trials (DCTs) Product and Solutions

2.10.4 Medable Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Medable Recent Developments and Future Plans

2.11 Science 37

2.11.1 Science 37 Details

2.11.2 Science 37 Major Business

2.11.3 Science 37 Decentralized Clinical Trials (DCTs) Product and Solutions

2.11.4 Science 37 Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Science 37 Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Decentralized Clinical Trials (DCTs) Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Decentralized Clinical Trials (DCTs) Players Market Share in 2021

3.2.2 Top 10 Decentralized Clinical Trials (DCTs) Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Decentralized Clinical Trials (DCTs) Players Head Office, Products and Services Provided

3.4 Decentralized Clinical Trials (DCTs) Mergers & Acquisitions

3.5 Decentralized Clinical Trials (DCTs) New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Decentralized Clinical Trials (DCTs) Revenue and Market Share by Type (2017-2022)

4.2 Global Decentralized Clinical Trials (DCTs) Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Application (2017-2022)

5.2 Global Decentralized Clinical Trials (DCTs) Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Decentralized Clinical Trials (DCTs) Revenue by Type (2017-2028)

6.2 North America Decentralized Clinical Trials (DCTs) Revenue by Application (2017-2028)

6.3 North America Decentralized Clinical Trials (DCTs) Market Size by Country

6.3.1 North America Decentralized Clinical Trials (DCTs) Revenue by Country (2017-2028)

6.3.2 United States Decentralized Clinical Trials (DCTs) Market Size and Forecast (2017-2028)

6.3.3 Canada Decentralized Clinical Trials (DCTs) Market Size and Forecast (2017-2028)

6.3.4 Mexico Decentralized Clinical Trials (DCTs) Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Decentralized Clinical Trials (DCTs) Revenue by Type (2017-2028)

7.2 Europe Decentralized Clinical Trials (DCTs) Revenue by Application (2017-2028)

7.3 Europe Decentralized Clinical Trials (DCTs) Market Size by Country

7.3.1 Europe Decentralized Clinical Trials (DCTs) Revenue by Country (2017-2028)

7.3.2 Germany Decentralized Clinical Trials (DCTs) Market Size and Forecast (2017-2028)

7.3.3 France Decentralized Clinical Trials (DCTs) Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Decentralized Clinical Trials (DCTs) Market Size and Forecast (2017-2028)

7.3.5 Russia Decentralized Clinical Trials (DCTs) Market Size and Forecast (2017-2028)

7.3.6 Italy Decentralized Clinical Trials (DCTs) Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Revenue by Type (2017-2028)

8.2 Asia-Pacific Decentralized Clinical Trials (DCTs) Revenue by Application (2017-2028)

8.3 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region

8.3.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Revenue by Region (2017-2028)

8.3.2 China Decentralized Clinical Trials (DCTs) Market Size and Forecast (2017-2028)

8.3.3 Japan Decentralized Clinical Trials (DCTs) Market Size and Forecast (2017-2028)

8.3.4 South Korea Decentralized Clinical Trials (DCTs) Market Size and Forecast (2017-2028)

8.3.5 India Decentralized Clinical Trials (DCTs) Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Decentralized Clinical Trials (DCTs) Market Size and Forecast (2017-2028)

8.3.7 Australia Decentralized Clinical Trials (DCTs) Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Decentralized Clinical Trials (DCTs) Revenue by Type (2017-2028)

9.2 South America Decentralized Clinical Trials (DCTs) Revenue by Application (2017-2028)

9.3 South America Decentralized Clinical Trials (DCTs) Market Size by Country

9.3.1 South America Decentralized Clinical Trials (DCTs) Revenue by Country (2017-2028)

9.3.2 Brazil Decentralized Clinical Trials (DCTs) Market Size and Forecast (2017-2028)

9.3.3 Argentina Decentralized Clinical Trials (DCTs) Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Decentralized Clinical Trials (DCTs) Revenue by Type (2017-2028)

10.2 Middle East & Africa Decentralized Clinical Trials (DCTs) Revenue by Application (2017-2028)

10.3 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country

10.3.1 Middle East & Africa Decentralized Clinical Trials (DCTs) Revenue by Country (2017-2028)

10.3.2 Turkey Decentralized Clinical Trials (DCTs) Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Decentralized Clinical Trials (DCTs) Market Size and Forecast (2017-2028)

10.3.4 UAE Decentralized Clinical Trials (DCTs) Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Decentralized Clinical Trials (DCTs) Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Decentralized Clinical Trials (DCTs) Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Decentralized Clinical Trials (DCTs) Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Decentralized Clinical Trials (DCTs) Revenue (USD Million) by Region (2017-2022)

Table 5. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Region (2023-2028)

Table 6. Medidata Corporate Information, Head Office, and Major Competitors

Table 7. Medidata Major Business

Table 8. Medidata Decentralized Clinical Trials (DCTs) Product and Solutions

Table 9. Medidata Decentralized Clinical Trials (DCTs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. IQVIA Corporate Information, Head Office, and Major Competitors

Table 11. IQVIA Major Business

Table 12. IQVIA Decentralized Clinical Trials (DCTs) Product and Solutions

Table 13. IQVIA Decentralized Clinical Trials (DCTs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Labcorp Corporate Information, Head Office, and Major Competitors

Table 15. Labcorp Major Business

Table 16. Labcorp Decentralized Clinical Trials (DCTs) Product and Solutions

Table 17. Labcorp Decentralized Clinical Trials (DCTs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. PRA Health Sciences Corporate Information, Head Office, and Major Competitors

Table 19. PRA Health Sciences Major Business

Table 20. PRA Health Sciences Decentralized Clinical Trials (DCTs) Product and Solutions

Table 21. PRA Health Sciences Decentralized Clinical Trials (DCTs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Parexel Corporate Information, Head Office, and Major Competitors

Table 23. Parexel Major Business

Table 24. Parexel Decentralized Clinical Trials (DCTs) Product and Solutions

Table 25. Parexel Decentralized Clinical Trials (DCTs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. ICON Corporate Information, Head Office, and Major Competitors

Table 27. ICON Major Business

Table 28. ICON Decentralized Clinical Trials (DCTs) Product and Solutions

Table 29. ICON Decentralized Clinical Trials (DCTs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Oracle Corporate Information, Head Office, and Major Competitors

Table 31. Oracle Major Business

Table 32. Oracle Decentralized Clinical Trials (DCTs) Product and Solutions

Table 33. Oracle Decentralized Clinical Trials (DCTs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. CRF Health Corporate Information, Head Office, and Major Competitors

Table 35. CRF Health Major Business

Table 36. CRF Health Decentralized Clinical Trials (DCTs) Product and Solutions

Table 37. CRF Health Decentralized Clinical Trials (DCTs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Clinical Ink Corporate Information, Head Office, and Major Competitors

Table 39. Clinical Ink Major Business

Table 40. Clinical Ink Decentralized Clinical Trials (DCTs) Product and Solutions

Table 41. Clinical Ink Decentralized Clinical Trials (DCTs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Medable Corporate Information, Head Office, and Major Competitors

Table 43. Medable Major Business

Table 44. Medable Decentralized Clinical Trials (DCTs) Product and Solutions

Table 45. Medable Decentralized Clinical Trials (DCTs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Science 37 Corporate Information, Head Office, and Major Competitors

Table 47. Science 37 Major Business

Table 48. Science 37 Decentralized Clinical Trials (DCTs) Product and Solutions

Table 49. Science 37 Decentralized Clinical Trials (DCTs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Global Decentralized Clinical Trials (DCTs) Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 51. Global Decentralized Clinical Trials (DCTs) Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 52. Breakdown of Decentralized Clinical Trials (DCTs) by Company Type (Tier 1, Tier 2 and Tier 3)

Table 53. Decentralized Clinical Trials (DCTs) Players Head Office, Products and Services Provided

Table 54. Decentralized Clinical Trials (DCTs) Mergers & Acquisitions in the Past Five Years

Table 55. Decentralized Clinical Trials (DCTs) New Entrants and Expansion Plans

Table 56. Global Decentralized Clinical Trials (DCTs) Revenue (USD Million) by Type (2017-2022)

Table 57. Global Decentralized Clinical Trials (DCTs) Revenue Share by Type (2017-2022)

Table 58. Global Decentralized Clinical Trials (DCTs) Revenue Forecast by Type (2023-2028)

Table 59. Global Decentralized Clinical Trials (DCTs) Revenue by Application (2017-2022)

Table 60. Global Decentralized Clinical Trials (DCTs) Revenue Forecast by Application (2023-2028)

Table 61. North America Decentralized Clinical Trials (DCTs) Revenue by Type (2017-2022) & (USD Million)

Table 62. North America Decentralized Clinical Trials (DCTs) Revenue by Type (2023-2028) & (USD Million)

Table 63. North America Decentralized Clinical Trials (DCTs) Revenue by Application (2017-2022) & (USD Million)

Table 64. North America Decentralized Clinical Trials (DCTs) Revenue by Application (2023-2028) & (USD Million)

Table 65. North America Decentralized Clinical Trials (DCTs) Revenue by Country (2017-2022) & (USD Million)

Table 66. North America Decentralized Clinical Trials (DCTs) Revenue by Country (2023-2028) & (USD Million)

Table 67. Europe Decentralized Clinical Trials (DCTs) Revenue by Type (2017-2022) & (USD Million)

Table 68. Europe Decentralized Clinical Trials (DCTs) Revenue by Type (2023-2028) & (USD Million)

Table 69. Europe Decentralized Clinical Trials (DCTs) Revenue by Application (2017-2022) & (USD Million)

Table 70. Europe Decentralized Clinical Trials (DCTs) Revenue by Application (2023-2028) & (USD Million)

Table 71. Europe Decentralized Clinical Trials (DCTs) Revenue by Country (2017-2022) & (USD Million)

Table 72. Europe Decentralized Clinical Trials (DCTs) Revenue by Country (2023-2028) & (USD Million)

Table 73. Asia-Pacific Decentralized Clinical Trials (DCTs) Revenue by Type (2017-2022) & (USD Million)

Table 74. Asia-Pacific Decentralized Clinical Trials (DCTs) Revenue by Type (2023-2028) & (USD Million)

Table 75. Asia-Pacific Decentralized Clinical Trials (DCTs) Revenue by Application (2017-2022) & (USD Million)

Table 76. Asia-Pacific Decentralized Clinical Trials (DCTs) Revenue by Application (2023-2028) & (USD Million)

Table 77. Asia-Pacific Decentralized Clinical Trials (DCTs) Revenue by Region (2017-2022) & (USD Million)

Table 78. Asia-Pacific Decentralized Clinical Trials (DCTs) Revenue by Region (2023-2028) & (USD Million)

Table 79. South America Decentralized Clinical Trials (DCTs) Revenue by Type (2017-2022) & (USD Million)

Table 80. South America Decentralized Clinical Trials (DCTs) Revenue by Type (2023-2028) & (USD Million)

Table 81. South America Decentralized Clinical Trials (DCTs) Revenue by Application (2017-2022) & (USD Million)

Table 82. South America Decentralized Clinical Trials (DCTs) Revenue by Application (2023-2028) & (USD Million)

Table 83. South America Decentralized Clinical Trials (DCTs) Revenue by Country (2017-2022) & (USD Million)

Table 84. South America Decentralized Clinical Trials (DCTs) Revenue by Country (2023-2028) & (USD Million)

Table 85. Middle East & Africa Decentralized Clinical Trials (DCTs) Revenue by Type (2017-2022) & (USD Million)

Table 86. Middle East & Africa Decentralized Clinical Trials (DCTs) Revenue by Type (2023-2028) & (USD Million)

Table 87. Middle East & Africa Decentralized Clinical Trials (DCTs) Revenue by Application (2017-2022) & (USD Million)

Table 88. Middle East & Africa Decentralized Clinical Trials (DCTs) Revenue by Application (2023-2028) & (USD Million)

Table 89. Middle East & Africa Decentralized Clinical Trials (DCTs) Revenue by Country (2017-2022) & (USD Million)

Table 90. Middle East & Africa Decentralized Clinical Trials (DCTs) Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Decentralized Clinical Trials (DCTs) Picture

Figure 2. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Type in 2021

Figure 3. Interventional

Figure 4. Observational

Figure 5. Expanded Access

Figure 6. Decentralized Clinical Trials (DCTs) Revenue Market Share by Application in 2021

Figure 7. Oncology Picture

Figure 8. Cardiovascular Picture

Figure 9. Others Picture

Figure 10. Global Decentralized Clinical Trials (DCTs) Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 11. Global Decentralized Clinical Trials (DCTs) Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Region (2017-2028)

Figure 13. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Region in 2021

Figure 14. North America Decentralized Clinical Trials (DCTs) Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Europe Decentralized Clinical Trials (DCTs) Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Asia-Pacific Decentralized Clinical Trials (DCTs) Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. South America Decentralized Clinical Trials (DCTs) Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Middle East and Africa Decentralized Clinical Trials (DCTs) Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Decentralized Clinical Trials (DCTs) Market Drivers

Figure 20. Decentralized Clinical Trials (DCTs) Market Restraints

Figure 21. Decentralized Clinical Trials (DCTs) Market Trends

Figure 22. Medidata Recent Developments and Future Plans

Figure 23. IQVIA Recent Developments and Future Plans

Figure 24. Labcorp Recent Developments and Future Plans

Figure 25. PRA Health Sciences Recent Developments and Future Plans

Figure 26. Parexel Recent Developments and Future Plans

Figure 27. ICON Recent Developments and Future Plans

Figure 28. Oracle Recent Developments and Future Plans

Figure 29. CRF Health Recent Developments and Future Plans

Figure 30. Clinical Ink Recent Developments and Future Plans

Figure 31. Medable Recent Developments and Future Plans

Figure 32. Science 37 Recent Developments and Future Plans

Figure 33. Global Decentralized Clinical Trials (DCTs) Revenue Share by Players in 2021

Figure 34. Decentralized Clinical Trials (DCTs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 35. Global Top 3 Players Decentralized Clinical Trials (DCTs) Revenue Market Share in 2021

Figure 36. Global Top 10 Players Decentralized Clinical Trials (DCTs) Revenue Market Share in 2021

Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 38. Global Decentralized Clinical Trials (DCTs) Revenue Share by Type in 2021

Figure 39. Global Decentralized Clinical Trials (DCTs) Market Share Forecast by Type (2023-2028)

Figure 40. Global Decentralized Clinical Trials (DCTs) Revenue Share by Application in 2021

Figure 41. Global Decentralized Clinical Trials (DCTs) Market Share Forecast by Application (2023-2028)

Figure 42. North America Decentralized Clinical Trials (DCTs) Sales Market Share by Type (2017-2028)

Figure 43. North America Decentralized Clinical Trials (DCTs) Sales Market Share by Application (2017-2028)

Figure 44. North America Decentralized Clinical Trials (DCTs) Revenue Market Share by Country (2017-2028)

Figure 45. United States Decentralized Clinical Trials (DCTs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Canada Decentralized Clinical Trials (DCTs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Mexico Decentralized Clinical Trials (DCTs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Europe Decentralized Clinical Trials (DCTs) Sales Market Share by Type (2017-2028)

Figure 49. Europe Decentralized Clinical Trials (DCTs) Sales Market Share by Application (2017-2028)

Figure 50. Europe Decentralized Clinical Trials (DCTs) Revenue Market Share by Country (2017-2028)

Figure 51. Germany Decentralized Clinical Trials (DCTs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. France Decentralized Clinical Trials (DCTs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. United Kingdom Decentralized Clinical Trials (DCTs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Russia Decentralized Clinical Trials (DCTs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Italy Decentralized Clinical Trials (DCTs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Asia-Pacific Decentralized Clinical Trials (DCTs) Sales Market Share by Type (2017-2028)

Figure 57. Asia-Pacific Decentralized Clinical Trials (DCTs) Sales Market Share by Application (2017-2028)

Figure 58. Asia-Pacific Decentralized Clinical Trials (DCTs) Revenue Market Share by Region (2017-2028)

Figure 59. China Decentralized Clinical Trials (DCTs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Japan Decentralized Clinical Trials (DCTs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. South Korea Decentralized Clinical Trials (DCTs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. India Decentralized Clinical Trials (DCTs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Southeast Asia Decentralized Clinical Trials (DCTs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Australia Decentralized Clinical Trials (DCTs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. South America Decentralized Clinical Trials (DCTs) Sales Market Share by Type (2017-2028)

Figure 66. South America Decentralized Clinical Trials (DCTs) Sales Market Share by Application (2017-2028)

Figure 67. South America Decentralized Clinical Trials (DCTs) Revenue Market Share by Country (2017-2028)

Figure 68. Brazil Decentralized Clinical Trials (DCTs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Argentina Decentralized Clinical Trials (DCTs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Middle East and Africa Decentralized Clinical Trials (DCTs) Sales Market Share by Type (2017-2028)

Figure 71. Middle East and Africa Decentralized Clinical Trials (DCTs) Sales Market Share by Application (2017-2028)

Figure 72. Middle East and Africa Decentralized Clinical Trials (DCTs) Revenue Market Share by Country (2017-2028)

Figure 73. Turkey Decentralized Clinical Trials (DCTs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Saudi Arabia Decentralized Clinical Trials (DCTs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. UAE Decentralized Clinical Trials (DCTs) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Methodology

Figure 77. Research Process and Data Source